Physician group Cellular Medicine Association stated on Monday that the US FDA has approved the use of the plasma (convalescent plasma) from the survivors of COVID-19 to be given as a life-saving treatment to those who may still be fighting to survive acute COVID-19 infection.
Cellular Medicine Association said people who survive COVID-19 harbor antibodies in their blood that fought the virus and won. Physicians struggle to quickly find the blood of a local person who has survived COVID-19 and who can donate the life-saving convalescent plasma, but the survivors do not know where to go to donate their blood.
The organisation has built a website, COVID19Switchboard.org, that connects those looking for blood and those wanting to give blood. This free switchboard works in every country (using Google Translate).
About 2000 company physicians and nurse practitioners in over 50 countries focus on connect potential donors with physicians through the procedures invented by Dr Runels--the Vampire Facelift, the Vampire Facial, the O-Shot and the Priapus Shot.
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
CARsgen Therapeutics' satri-cel NDA accepted by Chinese regulator
Sanofi receives FDA orphan drug designation for riliprubart in transplant rejection
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Hemab Therapeutics presents bleeding disorder clinical and preclinical data at ISTH 2025 Congress
Cumberland Pharmaceuticals reports ifetroban Phase 2 DMD heart disease trial results
Sarclisa recommended for EU approval in newly diagnosed transplant-eligible multiple myeloma